Sensitive skin numbing spray recalled over manufacturing practice deviations
Pro Numb Tattoo Numbing Spray LLC is recalling Pro Numb Tattoo Numbing Spray For Sensitive Skin, 4% Lidocaine, over cGMP deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 as a precautionary recall: the record cites generic cGMP deviations with no named contaminant, defect or reported harm.
Plain-English summary
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, in 1 FL OZ (28.4 mL) and 4 oz (120 mL) bottles, distributed by Pro Numb Tattoo Numbing Spray LLC of Melbourne, Florida, under NDC 83389-112-11, is being recalled.
The reason given in the enforcement record is cGMP deviations.
The record's quantity field reads 'N/A'. The recall covers lot number J15. Distribution was nationwide in the USA. The FDA has classified the action as Class II.
The record cites manufacturing practice deviations without naming a specific defect or contaminant, and reports no injuries. Consumers should follow the seller's return instructions.
The recalled product
- Product
- PRO NUMB SENSITIVE SKIN (NUMBING SPRAY)
- Brand
- PRO NUMB SENSITIVE SKIN
- Manufacturer
- Pro Numb Tattoo Numbing Spray LLC
- Category
- Drug — Topical anesthetic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot Number J15
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Pro Numb Tattoo Numbing Spray LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Pro Numb Tattoo Numbing Spray LLC
See all →- ModerateTattoo numbing spray recalled over manufacturing practice deviations
FDA (Drugs) · 2026-02-18
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19